NASDAQ: CGEMRUSSELL2000
Cullinan Therapeutics, Inc.
Healthcare · Medical - Pharmaceuticals · Headquartered in Cambridge, US
Price
Loading chart…
Overview
Cullinan Therapeutics, Inc. operates as a biopharmaceutical firm actively advancing its therapeutic candidates through clinical trials. This company is focused on developing innovative treatments primarily for cancer, including those that leverage the immune system (immuno-oncology). Its current roster of investigational drugs comprises CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. Patrick A. Baeuerle founded the organization on September 15, 2016, and it is presently headquartered in Cambridge, Massachusetts.
History & business model
This section is waiting to be written.
InvestWiki is community-edited. Contribute a plain-English history of Cullinan Therapeutics, Inc., its business model, key products, and controversies.